tRNA Gene Modification for Eukaryotic Translation Fidelity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current recombinant protein expression systems, particularly in eukaryotic hosts like mammalian cells, face challenges with base mismatch errors due to genetic degeneracy and reliance on wobble decoding, leading to inefficient translation and potential mis-incorporation of amino acids, which can compromise protein quality and safety.
Innovation Solution
Genetically modifying eukaryotic cells by transfecting or transforming them with tRNA genes that include anticodon sequences to correct base mismatches, thereby reducing reliance on wobble decoding and enhancing translation efficiency and fidelity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If wobble decoding is used to accommodate fewer tRNA species than codons, then translation can proceed with limited tRNA diversity, but base mismatch errors and amino acid misincorporation occur
Solution Approach 1:
The patent applies local quality by modifying specific tRNA molecules to have altered anticodon sequences that precisely match particular codons. Instead of relying on general wobble pairing, the invention creates specialized tRNAs with locally optimized anticodon-codon recognition, thereby improving translation fidelity at specific positions while maintaining overall system functionality
Solution Approach 2:
The invention changes the parameter of tRNA anticodon sequence composition to eliminate wobble-dependent base mismatches. By systematically modifying anticodon nucleotide sequences to achieve perfect Watson-Crick pairing with target codons, the patent transforms the translation system from one tolerant of mismatches to one requiring precise matching, thereby resolving the contradiction between limited tRNA diversity and high translation accuracy
2Productivity
If codon usage is optimized to match host preference, then translation efficiency improves, but transgene sequence manipulation may interfere with mRNA structure, folding, stability and regulation
Solution Approach 1:
The patent extracts the codon optimization problem from the transgene sequence itself and relocates it to the tRNA population. Instead of modifying the mRNA codon sequence (which would affect mRNA structure), the invention modifies the tRNA anticodon sequences to match the original codons, thereby achieving translation efficiency improvement without compromising mRNA structural integrity
Solution Approach 2:
The invention introduces modified tRNAs as intermediaries between the original codon sequence and the translation machinery. These engineered tRNAs serve as mediators that recognize specific codons with high fidelity without requiring changes to the mRNA sequence, thus decoupling the relationship between codon optimization and mRNA structural preservation
3Manufacturing precision
If additional tRNA transgenes are introduced to improve codon recognition, then translation fidelity improves in bacterial systems, but the approach has not been successfully attempted in eukaryotic hosts
Solution Approach 1:
The patent applies universality by developing a tRNA engineering platform that functions across different host systems. The modified tRNA constructs are designed to be universally applicable in eukaryotic expression systems, enabling the same principle of precise anticodon-codon matching to be implemented in mammalian, insect, and plant cells, thereby extending bacterial system successes to eukaryotic contexts
Data Source
Figure 1~2
Figure 3
Figure 4~5
AI summary
The disclosure relates to recombinant protein expression systems comprising genetically modified cells wherein the cells are transformed or transfected with tRNA genes to reduce base mismatch due to genetic degeneracy in the genetic code.